Carregant...
Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C?
In 2009, several groups reported that interleukin-28B (IL28B) genotypes are associated with the response to peginterferon plus ribavirin therapy for chronic hepatitis C virus (HCV) infection in a genome-wide association study, although the mechanism of this association is not yet well understood. Ho...
Guardat en:
| Publicat a: | World J Virol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Inc
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4534809/ https://ncbi.nlm.nih.gov/pubmed/26279979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5501/wjv.v4.i3.178 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|